{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:45:32Z","timestamp":1761093932325,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.anai.2018.07.007","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T10:12:51Z","timestamp":1537611171000},"page":"629-630.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Resolution of eosinophilia and elevated immunoglobulin E with ibrutinib for chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"121","author":[{"given":"Kaoru","family":"Harada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7580-4623","authenticated-orcid":false,"given":"Joel P.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis M.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anai.2018.07.007_bib0001","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaci.2010.04.011","article-title":"Practical approach to the patient with hypereosinophilia","volume":"126","author":"Roufosse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2018.07.007_bib0002","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jaci.2017.09.022","article-title":"Eosinophils and eosinophil-associated diseases: an update","volume":"141","author":"O'Sullivan","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2018.07.007_bib0003","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jaip.2015.06.009","article-title":"Hematologic malignancies identified in patients with hypereosinophilia and hypereosinophilic syndromes","volume":"3","author":"Jin","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.anai.2018.07.007_bib0004","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2018.07.007_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood.V75.1.13.13","article-title":"Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia","volume":"75","author":"Samoszuk","year":"1990","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.anai.2018.07.007_bib0006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/cimm.2001.1828","article-title":"Suppression of an IL-13 autocrine growth loop in a human Hodgkin\/Reed-Sternberg tumor cell line by a novel IL-13 antagonist","volume":"211","author":"Oshima","year":"2001","journal-title":"Cell Immunol"},{"issue":"8","key":"10.1016\/j.anai.2018.07.007_bib0007","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood.V93.8.2463","article-title":"Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia","volume":"93","author":"Teruya-Feldstein","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.anai.2018.07.007_bib0008","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/1042819031000068007","article-title":"IL-4 biology: impact on normal and leukemic CLL B cells","volume":"44","author":"Kay","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.anai.2018.07.007_bib0009","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1365-2141.2001.02605.x","article-title":"Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis","volume":"112","author":"Kay","year":"2001","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.anai.2018.07.007_bib0010","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood.V84.7.2297.2297","article-title":"Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4","volume":"84","author":"Mainou-Fowler","year":"1994","journal-title":"Blood"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618305684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618305684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:20:36Z","timestamp":1761052836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120618305684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1081120618305684"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2018.07.007","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resolution of eosinophilia and elevated immunoglobulin E with ibrutinib for chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2018.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}